Insurers returned $2B to consumers for 2020 under ACA
The rebates, tied to lower medical loss ratios, were triggered as utilization rates dropped at the start of the COVID-19 pandemic.
Moderna vaccine weaker against omicron, but third shot boosts protection
As a result of new laboratory data, the biotech company is deemphasizing more complex “multivalent” booster shots in favor of further study of its existing formulation and an omicron-specific version.
Nurses, Tenet hospital reach deal 9 months into strike
The two sides reached an agreement after two weeks of discussions with federal mediators, including a final in-person session mediated by U.S. Secretary of Labor Marty Walsh.
Cerner acquired by Oracle for $28B
The deal further pushes Oracle into the healthcare market, where its presence is mostly in data use efficiency for payers and providers. Oracle’s areas of focus include database software and cloud systems.
FDA warns about Log4j cybersecurity vulnerabilities in medical devices
The bugs in Apache’s Java-based open source logging library could potentially allow unauthorized users to remotely impact the safety and effectiveness of device functionality, according to the agency.
Hospitals clamp down on elective surgeries as COVID-19 surges
Cleveland Clinic, Banner Health and other hospital systems are pausing nonessential procedures, while provider groups issued a joint statement Friday declaring that doctors and nurses are exhausted and heartbroken.
Achieving a new vision of health care delivery depends on our nurses
In the face of a national crisis, now is the time to invest in attracting and retaining great talent for patient care.
Physician compensation rises alongside burnout, retirements in 2021
Over 73% of physicians reported feeling overworked amid the pandemic and 50% said they are considering an employment change because of it, Doximity’s annual report found.
J&J’s coronavirus vaccine faces new US limits
Days after the FDA strengthened safety warnings for the company’s shot, a CDC panel recommended Pfizer’s and Moderna’s vaccines be “preferred” over J&J’s.
3 medtech markets poised to thrive in 2022 despite renewed COVID-19 pressures
While the emergence of the omicron variant is muddying next year’s medtech outlook, analysts have identified three niches within the sector best positioned to successfully weather the continued strains on the healthcare system.